Sire Group Ltd. 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-21 08:32 am Unchanged | 2024-08-19 | 13D | Titan Pharmaceuticals, Inc. TTNP | Sire Group Ltd. | 150,087 14.100% | 0 (Unchanged) | Filing |
| 2024-04-05 4:34 pm Purchase | 2024-04-05 | 13D | Titan Pharmaceuticals, Inc. TTNP | Sire Group Ltd. | 150,087 14.100% | 150,087 (New Position) | Filing |